FDA’s Acting Chief Scientist Offers Vaccine Continuity As Goodman Departs
This article was originally published in The Pink Sheet Daily
Executive Summary
Jesse Goodman will become director of Georgetown University’s new Center on Medical Product Access, Safety and Stewardship while Stephen Ostroff steps up as FDA’s Acting Chief Scientist.
You may also be interested in...
FDA Reorganization Will Not Include John Taylor, Hamburg’s Great Actor
Taylor’s exit from the agency comes as commissioner awaits recommendations from a panel of senior agency officials on how to ensure the centers support Office of Regulatory Affairs’ activities without duplication.
FDA Needs 5 To 10 Years Of Rebuilding, Chief Scientist Goodman Says
At Hill briefing, Rep. DeLauro praises the Sentinel initiative and Commissioner Hamburg but expresses dismay about the "knowledge shortfall" at the agency.
State Of The Science At FDA: Catching Up With Jesse Goodman
As the swine flu pandemic shows signs of leveling off, FDA Chief Scientist Jesse Goodman is ready to turn attention back to his original mission: improving the agency's scientific capacity and integrity